Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

Stroke Prevention in Atrial Fibrillation

(2015) Gregory Y. H. Lip et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial

(2015) Jessica L Mega et al.   LANCET

Economic evaluation of a pharmacogenetic dosing algorithm for coumarin anticoagulants in The Netherlands

(2015) Talitha I Verhoef et al.   PHARMACOGENOMICS

Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation

(2013) J Pink et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon

(2013) Talitha I. Verhoef et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

(2013) Stephen E. Kimmel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Genotype-Guided Dosing of Warfarin

(2013) Munir Pirmohamed et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost–effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation

(2013) Talitha I Verhoef et al.   PHARMACOGENOMICS

Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries

(2012) Harriette G.C. Van Spall et al.   CIRCULATION

Population-Based Study of Acute- and Long-Term Care Costs after Stroke in Patients with AF

(2012) Ramon Luengo-Fernandez et al.   International Journal of Stroke

Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs

(2012) Talitha I Verhoef et al.   PHARMACOGENOMICS

Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation

(2011) Shimoli V. Shah et al.   CIRCULATION

Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes

(2011) Rebecca Howard et al.   CLINICA CHIMICA ACTA

A Proposal for an Individualized Pharmacogenetics-Based Warfarin Initiation Dose Regimen for Patients Commencing Anticoagulation Therapy

(2011) P J Avery et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA

(2011) M. Wieloch et al.   EUROPEAN HEART JOURNAL

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

(2010) P Lenzini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives

(2010) Talitha I Verhoef et al.   PHARMACOGENOMICS

Pharmacogenetics of Oral Anticoagulant Therapy

(2009) T. Schalekamp et al.   CURRENT PHARMACEUTICAL DESIGN

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing

(2009) Lisa M. Meckley et al.   PHARMACOECONOMICS

Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model

(2009) Björn Schwander et al.   VALUE IN HEALTH

The largest prospective warfarin-treated cohort supports genetic forecasting

(2008) M. Wadelius et al.   BLOOD

Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis

(2008) N. Oake et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

A Multinational Investigation of Time and Traveling Costs in Attending Anticoagulation Clinics

(2007) Sue Jowett et al.   VALUE IN HEALTH